Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
1.
Eur Rev Med Pharmacol Sci ; 23(1 Suppl): 60-66, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30920634

ABSTRACT

OBJECTIVE: Probiotics S. salivarius 24SMBc and S. oralis 89a comprised in the nasal spray Rinogermina are known to exert inhibition of harmful pathogens and ameliorate the outcome of patients with chronic upper airways infections. In this study, for the first time, the effect of this formulation on the modulation of the microflora of healthy subjects was evaluated, with particular interest on pathobionts and pathogens present. PATIENTS AND METHODS: Metagenomic identification and quantification of bacterial abundances in healthy subjects were carried out by means of Ion Torrent Personal Machine. In particular, nasal swabs were sampled one, two and four weeks after seven days of treatment with Rinogermina. RESULTS: The modulation of the abundance of pathobionts and pathogenic species (i.e., Corynebacterium diphtheriae, Haemophilus parainfluenzae, Moraxella catarrhalis, Prevotella denticola, Prevotella melaninogenica, Rothia dentocariosa, Staphylococcus aureus and Streptococcus pseudopneumoniae) was characterized and a significant temporary decrease in their presence was identified. CONCLUSIONS: The beneficial effects of S. salivarius 24SMBc and S. oralis 89a nasal intake was assessed but seemed to be restricted in specific temporal windows. Thus it would be interesting to evaluate also this positive impact of longer administration of this probiotic formulation.


Subject(s)
Microbiota/drug effects , Nose/microbiology , Probiotics/pharmacology , Streptococcus oralis , Streptococcus salivarius , Administration, Intranasal , Adult , Female , Healthy Volunteers , Humans , Male , Middle Aged , Probiotics/administration & dosage , Time Factors , Young Adult
2.
Phlebology ; 28(8): 441-4, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23188814

ABSTRACT

OBJECTIVE: To assess the presence of pulmonary embolism and inflammation after polidocanol foam injection into the peripheral veins of rabbits. METHOD: The animals were treated with polidocanol foam (1 or 3 mg/kg) or vehicle. Early (15 minutes) and late (30 days) animals were evaluated by perfusional lung scintigraphy and histopathological examination. RESULTS: In the control group no alterations were found. After polidocanol foam injection it was observed that an important reduction of pulmonary perfusion in the early periods, was mainly in the left lung (P < 0.001), with consequent embolism in the histological evaluation. In late periods it was observed that the presence of thrombus was with fibrin in small veins, compatible with chronic thrombus and the presence of chronic pulmonary inflammation. CONCLUSIONS: The injection of polidocanol foam in experimental animals can induce venous embolism and chronic inflammatory infiltration.


Subject(s)
Lung/blood supply , Lung/pathology , Polyethylene Glycols/adverse effects , Pulmonary Embolism/chemically induced , Pulmonary Embolism/pathology , Sclerosing Solutions/adverse effects , Acute Disease , Animals , Chronic Disease , Female , Male , Polidocanol , Polyethylene Glycols/pharmacology , Rabbits , Sclerosing Solutions/pharmacology , Time Factors
3.
J Inorg Biochem ; 99(12): 2381-6, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16266751

ABSTRACT

A solution study on the ability of some derivatised sugars [glucuronic acid (GluA), galacturonic acid (GalA) and glucosaminic acid (GlNA)] to complex the Hg(II) ion is reported. The stability constants of the complex species were determined by potentiometric measurements while (1)H NMR experiments allow to define the coordination sites of sugar molecules. GluA coordinates the metal ion through the carboxylic oxygen and the O-4 hydroxyl group and is found to form more stable complexes with respect to GalA in which metal ligation is from the carboxylic oxygen and the O-5 ring oxygen. GlNA forms stable complexes chelating Hg(II) ion through carboxylic oxygen and the alpha-amino group. The ternary 2,2'-bipyridine containing systems were also investigated by means of potentiometric studies. The ML(2) complexes were also isolated in the solid state and characterised by IR spectroscopy.

4.
J Inorg Biochem ; 85(2-3): 123-9, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11410232

ABSTRACT

Silybin, a natural occurring flavolignan isolated from the fruits of Silibum marianum, has been reported to exert antioxidant and free radical scavenging abilities. It was suggested to act also as an iron chelator. The complexation and protonation equilibria of the ferric complex of this compound have been studied by potentiometric, spectrophotometric and electrochemical techniques. The formation of the complex silybin-Ga(III) in anhydrous DMSO-d6 has been studied by 1H NMR spectroscopy. Mass spectrometry and infrared spectroscopy on silybin-Fe(III) complex confirm all data obtained by 1H NMR spectroscopy. The experimental results show that silybin binds Fe(III) even at acidic pH. Different ternary complexes were observed at increasing methoxide ion concentration and their stability constants have been calculated. The results show the possible role of silybin in relation to the chelation therapy of chronic iron overload, as occurs in the treatment of Cooley's anemia.


Subject(s)
Fruit/chemistry , Iron Chelating Agents/chemistry , Silymarin/chemistry , Antioxidants/chemistry , Dimethyl Sulfoxide , Drug Stability , Electrochemistry , Gallium/chemistry , Hydrogen-Ion Concentration , Iron/chemistry , Ligands , Nuclear Magnetic Resonance, Biomolecular , Organometallic Compounds/chemistry , Plant Extracts/chemistry
5.
J Am Podiatr Med Assoc ; 91(2): 93-5, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11266485

ABSTRACT

Clinically, a venous aneurysm is seen as a nonpulsatile mass with shrinkage upon elevation and enlargement with dependency. Confirmation of the diagnosis is best made by venography. In the case presented here of a rare aneurysm of the dorsal venous arch, the diagnosis of venous aneurysm was based on the histopathologic and intraoperative findings. If a venous aneurysm is symptomatic, it should be excised, with ligation of all feeder veins. In all cases, accurate preoperative diagnosis and evaluation allows for appropriate surgical planning.


Subject(s)
Aneurysm , Foot/blood supply , Adult , Aneurysm/diagnosis , Female , Foot Diseases/diagnosis , Humans , Veins
6.
Horm Metab Res ; 30(10): 646-7, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9851675

ABSTRACT

Body weight (BW), body mass index (BMI), body fat, serum leptin concentration and resting energy expenditure (REE) were fitted in a multiple linear regression model in a group of individuals with stable body weight. While serum leptin concentration was well related to BW, to BMI and to body fat, no correlations with the REE values were found. This suggests that serum leptin concentration would represent an index of adiposity and poorly reflects energy metabolism.


Subject(s)
Body Composition , Energy Metabolism , Proteins/metabolism , Adipose Tissue , Adult , Body Mass Index , Body Weight , Female , Humans , Leptin , Linear Models , Male , Middle Aged
7.
Seizure ; 7(5): 415-6, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9808120

ABSTRACT

Treatment of seizures in acute intermittent porphyria represents a therapeutic dilemma. Patients needing chronic therapy often experience acute porphyric attacks due to increased hepatic metabolism induced by the antiepileptic drugs themselves. Gabapentin is a new antiepileptic drug not appreciably metabolized by the liver in humans, and it appears to be safe and effective in the maintenance therapy of epilepsy in these patients. We report a patient affected by partial and generalized seizures in the course of acute intermittent porphyria, who was safely and successfully treated with gabapentin.


Subject(s)
Acetates/therapeutic use , Amines , Anticonvulsants/therapeutic use , Cyclohexanecarboxylic Acids , Epilepsy/drug therapy , Porphyria, Acute Intermittent/complications , gamma-Aminobutyric Acid , Adult , Epilepsy/complications , Female , Gabapentin , Humans , Treatment Outcome
8.
Kidney Int ; 46(4): 1124-32, 1994 Oct.
Article in English | MEDLINE | ID: mdl-7861707

ABSTRACT

The aim of this study was to assess the effect of a long-term course of high-dose i.v. pulses of calcitriol (CLT) on hyperparathyroid bone disease (HBD) and functional mass of parathyroid glands of chronically hemodialyzed uremic (CHU) patients. We prospectively studied nine CHU patients treated with CLT, 30 ng/kg/body wt, i.v., thrice weekly over a period of eight months. Plasma concentrations of intact parathyroid hormone (iPTH), bone GLA protein (bGLA) and bone isoenzyme of alkaline phosphatase (biALP) were sampled throughout. Transiliac bone biopsies were made before and after the start of CLT therapy. Double scanning scintigraphy of the neck with 201Tl-99Tc was made before, during and eight months after the start of the treatment. All patients but one, who later responded to higher than planned CLT doses, had significant decreases of plasma iPTH (F = 76; P < 0.0001; ANOVA). The mean pretreatment value of PTH was 966 +/- 160 (mean +/- SE) pg/ml and it had decreased significantly by the first week (T = 2.4, P < 0.04), and had fallen an average of 80% by the 35th week. Ionized plasma calcium concentration was 1.19 +/- .01 mmol/liter which rose significantly (F = 13.5; P < 0.0001) by the 14th week to maximal peak levels, averaging 1.34 +/- .02 mmol/liter. Changes in biALP were parallel to those of iPTH, while bGLA tended to increase immediately after the start of the therapy and to significantly decrease thereafter (T = 3.2; P < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Calcitriol/therapeutic use , Hyperparathyroidism, Secondary/drug therapy , Uremia/complications , Adult , Aged , Alkaline Phosphatase/blood , Bone and Bones/pathology , Calcitriol/administration & dosage , Chronic Kidney Disease-Mineral and Bone Disorder/drug therapy , Chronic Kidney Disease-Mineral and Bone Disorder/etiology , Chronic Kidney Disease-Mineral and Bone Disorder/pathology , Female , Humans , Hyperparathyroidism, Secondary/blood , Hyperparathyroidism, Secondary/etiology , Injections, Intravenous , Isoenzymes/blood , Longitudinal Studies , Male , Middle Aged , Osteocalcin/blood , Parathyroid Glands/pathology , Parathyroid Hormone/blood , Prospective Studies , Renal Dialysis , Uremia/therapy
9.
Minerva Anestesiol ; 60(9): 427-35, 1994 Sep.
Article in Italian | MEDLINE | ID: mdl-7808647

ABSTRACT

OBJECTIVE: Purpose of the study was clinical evaluation of thymopentin and interleukins in the changes of immunity due to anesthesia and surgical operation. DESIGN: After randomization the patients were divided into four groups according to starter type (thiopental or propofol) and immunological pre-treatment (tymopentin or saline of control group) administered for three days before and two days after operation. SETTING AND PATIENTS: The study was effected on 40 patients undergoing venous vascular surgery in operating rooms of Medical School of University of Genoa. MEASUREMENT: At pre-established times (basal, before and after induction, recovery and 72 postoperative hours) were measured some immunological data (plasmatic concentrations of red blood cells, white blood cells, lymphocyte cells, antibodies, complement analysis, interleukins 1 and 2). RESULTS: The results show a depression of immunity with hypoleucocistosis and hyperlymphocytosis due to surgical trauma or to anesthesia drugs. CONCLUSIONS: Pre-treatment with thymopentin no change perioperative immunity and the role of interleukins isn't clear; the immunological depression is the same in thiopental of propofol groups.


Subject(s)
Anesthesia/adverse effects , Interleukin-1/blood , Interleukin-2/blood , Leukopenia/etiology , Lymphocytosis/etiology , Postoperative Complications/immunology , Propofol/adverse effects , Thiopental/adverse effects , Thymopentin/therapeutic use , Adult , Aged , Double-Blind Method , Female , Humans , Leukopenia/prevention & control , Lymphocytosis/prevention & control , Male , Middle Aged , Premedication , Thymopentin/administration & dosage , Varicose Veins/surgery
10.
Ital J Neurol Sci ; 15(2): 121-3, 1994 Mar.
Article in English | MEDLINE | ID: mdl-8056555

ABSTRACT

Congenital protein S deficiency is an important risk factor for venous and, more rarely, arterial thrombosis. Here, we describe the case of a 35-year old patient with cerebral ischemia, protein S deficiency and carotid stenosis. Other members of the family were found to have the same protein S deficit and a history of venous thrombotic manifestations.


Subject(s)
Brain Ischemia/etiology , Carotid Stenosis/complications , Protein S Deficiency , Adult , Brain Ischemia/diagnostic imaging , Carotid Stenosis/diagnostic imaging , Cerebral Angiography , Humans , Male , Tomography, X-Ray Computed
11.
Clin Ter ; 141(7): 47-50, 1992 Jul.
Article in Italian | MEDLINE | ID: mdl-1505176

ABSTRACT

Twenty eight patients with heterozygous familial hypercholesterolemia were treated with mevalonic acid (an inhibitor of cholesterol synthesis) for 45 days. Patients received a daily dose of 750 to 1500 mg mevalonic acid depending on plasma cholesterol levels. Results showed a significant reduction in cholesterol values whereas no significant difference was observed in HDL cholesterol and triglyceride levels.


Subject(s)
Anticholesteremic Agents/therapeutic use , Hyperlipoproteinemia Type II/drug therapy , Mevalonic Acid/therapeutic use , Adult , Aged , Cholesterol/blood , Cholesterol, HDL/blood , Drug Evaluation , Female , Humans , Hyperlipoproteinemia Type II/blood , Male , Middle Aged , Triglycerides/blood
12.
Minerva Anestesiol ; 58(5): 245-51, 1992 May.
Article in Italian | MEDLINE | ID: mdl-1635633

ABSTRACT

The score scale of anxiety (STAI, Y, 1-2) and haematic levels of DBI (diazepam binding inhibitor) were used in 48 surgical patients for clinical evaluation of preoperative anxiety, before and after drugs for preoperative medication. After randomization, were clinically and statistically compared 6 groups according to premedicant drugs (diazepam 0.3 mg/kg; flunitrazepam 0.03 mg/kg; saline; prometazine 0.7 mg/kg); before and after preoperative medication were evaluated the anxiety relief with the score scale, haematic levels of DBI and haemodynamics (systolic and diastolic AP and HR). The results show that DBI can objectively measure the anxiety relief, that not are correlate haematic levels of DBI and score scale, that the best benzodiazepines are diazepam (0.3) and flunitrazepam (0.015) and that the prometazine might give anxiety relief for 5-HT antagonist action. Even if there are limits to study (scanty cases, are missing the range and the brain values of DBI and blood test of DBI is slow method) may be useful the use of score scale and haematic levels of DBI in clinical evaluation of preoperative anxiety relief.


Subject(s)
Anxiety/drug therapy , Neuropeptides/blood , Preanesthetic Medication , Surgical Procedures, Operative/psychology , Adult , Aged , Anxiety/blood , Diazepam/therapeutic use , Diazepam Binding Inhibitor , Female , Flunitrazepam/therapeutic use , Humans , Male , Middle Aged , Preoperative Care , Promethazine/therapeutic use
13.
Hepatogastroenterology ; 38 Suppl 1: 63-6, 1991 Dec.
Article in English | MEDLINE | ID: mdl-1823067

ABSTRACT

The chief cell mass, expressed as the Zymogenous Index (number of cells per mm2 multiplied by the thickness of the glandular layer) was calculated in 42 subjects with chronic gastritis, and in 40 subjects with normal gastric mucosa, and was compared with the serum concentration of Pepsinogen I (PG I), with the parietal cell mass (expressed as Parietal Index: number of cells per mm2 multiplied by the thickness of the glandular layer), and with the acid output. The results showed that there are no significant variations in the chief cells in comparison with healthy controls in the case of superficial gastritis and follicular gastritis. Conversely, in the case of pre-atrophic and atrophic gastritis there is a significant reduction in the chief cell mass. The serum PG I increases significantly in the case of superficial gastritis as compared with healthy controls, while it is equivalent in the case of follicular gastritis, decreases non-significantly in pre-atrophic gastritis and is significantly reduced in the case of atrophic gastritis. The parietal cell mass shows a behavior equivalent to that of the chief cell mass, and the acid output decreases significantly in the case of pre-atrophic and atrophic gastritis, with no significant variations in the case of superficial and follicular gastritis. On comparing the behavior of the chief cell mass with that of the parietal cell mass, it was noticed that in the most severe stages of chronic gastritis there is a more pronounced reduction of the former than of the latter.


Subject(s)
Gastric Mucosa/cytology , Gastritis/pathology , Adult , Aged , Cell Count , Chronic Disease , Female , Gastric Mucosa/pathology , Gastritis/metabolism , Humans , Male , Middle Aged , Parietal Cells, Gastric/metabolism , Parietal Cells, Gastric/pathology , Pepsinogens/blood , Severity of Illness Index
15.
Boll Soc Ital Biol Sper ; 67(3): 273-8, 1991 Mar.
Article in Italian | MEDLINE | ID: mdl-1930902

ABSTRACT

Subclinical elevation of urinary albumin excretion is a good predictor of later clinical proteinuria. A simple, sensitive and rapid immunoturbidimetric method was developed to quantify urinary albumin excretion (URIN-PAK ImmunoMICRO LAB, Miles Italia Spa). In the presence of polyethylene glycol 6000, immunocomplex between human albumin and its specific antibody are rapidly formed (5-50 min, at room temperature). Absorbance reading are mode U 340 nm (Automatic Analyzer RA 1000, Technicon). The test is specific for albumin failing to cross react with other plasma proteins present in urine, as well as with glibenclamide, chlorpropamide, phenformin, hemoglobin, glucose, urea and thymol. The present method correlates with SCLAVO H-ALBUMIN RIA Kit (r = 0.9917). The test is suitable for clinical use.


Subject(s)
Albuminuria/urine , Diabetic Nephropathies/urine , Nephelometry and Turbidimetry/methods , Precipitin Tests , Albuminuria/diagnosis , Albuminuria/epidemiology , Albuminuria/etiology , Antigen-Antibody Complex/urine , Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 1/urine , Diabetic Nephropathies/diagnosis , Diabetic Nephropathies/epidemiology , Humans , Predictive Value of Tests , Prevalence , Radioimmunoassay/methods , Reagent Kits, Diagnostic , Urine/chemistry
16.
Minerva Chir ; 45(20): 1273-80, 1990 Oct 31.
Article in Italian | MEDLINE | ID: mdl-2082204

ABSTRACT

The clinical field in which tumor markers proved to be most useful is the monitoring of cancer patients. The present study was carried out in order to evaluate the role of tumor markers in the prognostic assessment, and pre-clinical identification of disease recurrence in patients with completely resectable non-small cell bronchial carcinoma. Tumor markers have been measured: a) pre-operatively, in 109 patients with resectable lung cancer and b) post-operatively, in 61 patients who underwent complete resections and were followed for at least one year after surgery. The carcinoembryonic antigen (CEA), the neuron specific enolase (NSE), the tissue polypeptide antigen (TPA), the carbohydrate antigen 19-9 (CA 19-9) and the carbohydrate antigen 50 (CA 50) have been determined in each patient. Long-term survival was significantly correlated with serum levels of the CEA, CA 50 and CA 19-9, while not with those of TPA and NSE. For pre-clinical detection of cancer recurrence, TPA and NSE were the most suitable indicators.


Subject(s)
Adenocarcinoma/surgery , Biomarkers, Tumor/analysis , Carcinoma, Squamous Cell/surgery , Lung Neoplasms/surgery , Adenocarcinoma/diagnosis , Adenocarcinoma/mortality , Adult , Aged , Antigens, Tumor-Associated, Carbohydrate/analysis , Carcinoembryonic Antigen/analysis , Carcinoma, Squamous Cell/diagnosis , Carcinoma, Squamous Cell/mortality , Enzyme-Linked Immunosorbent Assay , Follow-Up Studies , Humans , Lung Neoplasms/diagnosis , Lung Neoplasms/mortality , Middle Aged , Peptides/analysis , Phosphopyruvate Hydratase/analysis , Prognosis , Radioimmunoassay , Time Factors , Tissue Polypeptide Antigen
17.
Minerva Chir ; 45(20): 1265-72, 1990 Oct 31.
Article in Italian | MEDLINE | ID: mdl-1964495

ABSTRACT

The present study has been carried out in order to evaluate the role of tumor markers in the presurgical assessment of patients with bronchial carcinoma. The carcinoembryonic antigen (CEA), the neuron specific enolase (NSE), the tissue polypeptide antigen (TPA), the carbohydrate antigen 19-9 (CA 19-9) and the carbohydrate antigen 50 (CA 50) have been preoperatively measured in 133 subjects with potentially resectable lung cancers, and in 75 healthy smokers. Sixty-one patients had squamous cell carcinoma, 55 adenocarcinoma and 17 small cell carcinoma. Lobectomy (or bilobectomy) was performed in 74 cases, pneumonectomy in 36 cases, exploratory thoracotomy in 15 cases and a palliative resection in 8 cases. When individual markers were considered, TPA showed the highest sensitivity (85%) and CA 19-9 the lowest sensitivity (11%). Specificity was uniformly superior to 90%. When marker associations were considered, the combined measurement of TPA and NSE gave the best results: both the sensitivity and specificity rates approached 90%. The application of the TPA-NSE association allowed detection of 94% of small cell carcinomas, 89% of adenocarcinomas and 85% of squamous cell carcinomas. A positive correlation was found between the complete resectability of lung cancer and serum levels of CEA, CA 50 and CA 19-9. By using the discriminant analysis, a statistical model yielding identification of about 74% of patients with tumors which were judged potentially resectable according to the pre-operative non-invasive diagnostic procedures and were found to be unresectable at thoracotomy, has been get available.


Subject(s)
Adenocarcinoma/diagnosis , Biomarkers, Tumor/analysis , Carcinoma, Small Cell/diagnosis , Carcinoma, Squamous Cell/diagnosis , Lung Neoplasms/diagnosis , Adenocarcinoma/surgery , Aged , Antigens, Tumor-Associated, Carbohydrate/analysis , Carcinoembryonic Antigen/analysis , Carcinoma, Small Cell/surgery , Carcinoma, Squamous Cell/surgery , Enzyme-Linked Immunosorbent Assay , Female , Humans , Lung Neoplasms/surgery , Male , Middle Aged , Peptides/analysis , Phosphopyruvate Hydratase/analysis , Preoperative Care , Radioimmunoassay , Tissue Polypeptide Antigen
18.
Pediatr Med Chir ; 12(3): 239-41, 1990.
Article in Italian | MEDLINE | ID: mdl-2274434

ABSTRACT

In 35 patients (13F/22M; age range 2-15 years), affected by insulin dependent diabetes mellitus (IDDM), basal and glucagon stimulated C peptide was determined and correlated with the daily insulin requirement (U/Kg/die), the glycosylated hemoglobin (HbA1c), the age of onset (months) and the length of the illness (months). The results of C peptide determinations are illustrated in tab. 1: in 20 patients (group I) the basal value of C peptide is higher than 1 ng/ml and increases after glucagon load; in 15 patients (group II) the basal value of C peptide is lower than 1 ng/ml; in 9 ones (group IIA) of these 15 a glucagon load does not elicit a residual insulin secretion; in the other 6 ones (group IIB) a significative C peptide increase is observed after glucagon load. A better metabolic control (p less than 0.01); Student t test) and a shorter length of the illness (p less than 0.05; Mann-Withney U test) was noticed in the group I in comparison with the group IIA, in which no insulin reserve, even after glucagon load, was demonstrated (tab. 2). However, no difference in the metabolic control, insulin requirement, age of onset or length of the illness resulted between group IIA and group IIB (in which an insulin reserve had been demonstrated only after glucagon load). The basal C peptide evaluation and follow up is useful in the assessment of the individual case of IDDM: a glucagon load may demonstrate a residual insulin reserve in some patients with a low basal C peptide.


Subject(s)
Diabetes Mellitus, Type 1/physiopathology , Glucagon , Islets of Langerhans/physiopathology , Peptides/blood , Adolescent , Child , Child, Preschool , Diabetes Mellitus, Type 1/blood , Female , Glycated Hemoglobin/analysis , Humans , Insulin/blood , Male
19.
Riv Eur Sci Med Farmacol ; 12(2): 99-102, 1990 Apr.
Article in Italian | MEDLINE | ID: mdl-2080314

ABSTRACT

The vasoactive intestinal peptide (VIP) concentrations in the pulmonary and systemic arterial blood were evaluated in 11 asthmatic patients in symptom-free period and during methacholin induced broncospasm. The basal venous and arterial mean values do not significantly differ. A significant difference was observed after bronchial challenge. This could be caused by an increased VIP pulmonary production as a defensive mechanism. No correlation was found between bronchial reactivity (as PD20-FEV1 Methacholin) and VIP concentrations.


Subject(s)
Asthma/metabolism , Lung/metabolism , Vasoactive Intestinal Peptide/metabolism , Adult , Aged , Asthma/blood , Female , Humans , Male , Middle Aged , Vasoactive Intestinal Peptide/blood
20.
Gastroenterol Clin Biol ; 14(2): 158-62, 1990.
Article in English | MEDLINE | ID: mdl-2328882

ABSTRACT

In the present study, a counting method for the evaluation of chief cell mass was proposed, based on the assessment of a zymogenous index (ZI) obtained by multiplying the number of cells/mm2 by the thickness of the glandular layer. Results obtained in 40 subjects with normal gastric mucosa did not show significant ZI differences between sexes. A statistically significant decrease in ZI was observed in patients above age 50, thus being directly related to the significant decrease in the thickness of the glandular parenchyma and in the number of chief cells/mm2 observed in this age group. The data obtained were in agreement with the pattern of change observed for serum pepsinogen I (PG I) whose values were related to the chief cell mass in connection with sex and age of the subjects.


Subject(s)
Cell Count/methods , Gastric Mucosa/cytology , Pepsinogens/blood , Adolescent , Adult , Age Factors , Aged , Child , Female , Humans , Male , Middle Aged , Parietal Cells, Gastric/cytology
SELECTION OF CITATIONS
SEARCH DETAIL
...